Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

david_paul_morrisbloomberg

Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows

June 2, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …

News

How Big Brother is helping to fight COVID-19

June 1, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace

Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …

Feature
shutterstock_243110086

First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment

May 29, 2020
Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir

The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …

News
shutter

MSD and Eisai announce meaningful objective response rates for Keytruda+Lenvima combo in two cancer patient populations

May 29, 2020
Medical Communications, Research and Development Lenvima, keytruda, pharma

MSD has pulled back the curtain on new data from two trials of its anti-PD-1 immunotherapy Keytruda (pemvbrolizmuab) in combination …

News
gsk_boronia_australia

GlaxoSmithKline commits to the production of one billion doses of COVID-19 vaccine adjuvant in 2021

May 28, 2020
Manufacturing and Production COVID-19, GSK, coronavirus, pharma, vaccines

GlaxoSmithKline has just come forward to commit to the manufacture and distribution of one billion doses of vaccine adjuvant against …

News
pharmafocus_june_2020_front_cover

The June 2020 issue of Pharmafocus is available to read free online now!

May 27, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access

The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …

News
49891315508_8849365d96_c

Cleaning staff excluded from GSK’s £1.5k COVID-19 employee bonus

May 26, 2020
Manufacturing and Production COVID-19, GSK, coronavirus, pharma

UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …

News
moderna-605x340

Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope

May 19, 2020
Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma

Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …

News
astrazeneca_sign_sky

AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine

May 19, 2020
Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma

AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …

News
shutterstock

New study on COVID-19 immune response shows promise for vaccine development

May 18, 2020
Research and Development, Sales and Marketing COVID-19, coronavirus, pharma

Researchers at the labs of Dr Alessandro Sette and Dr Shane Crotty at California’s La Jolla Institute for Immunology have …

News

Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues

May 15, 2020
Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma

Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …

News
janssen_latest_logo_on_sign_closer

100% of multiple myeloma patients respond to Janssen’s investigational CAR T therapy, data shows

May 14, 2020
Research and Development CAR T, CAR-T, Janssen, multiple myeloma, pharma

Janssen has revealed new Phase1b/2 findings of the efficacy of its investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell …

News
japan_mhlw

Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19

May 12, 2020
Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir

Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …

News
laree2

What can previous outbreak modeling tell us about the COVID-19 pandemic?

May 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Interview, coronavirus, feature, pharma

Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …

Feature

FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14

May 7, 2020
Sales and Marketing Incyte, Novartis, Tabrecta, pharma

The FDA has awarded marketing authorisation to Novartis for the Oral MET inhibitor Tabrecta (capmatinib) for the first-line treatment of metastatic non-small …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026